We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Reducing the impact of future pandemics by making Diagnostics, Therapeutics and Vaccines available within 100 days. A report to the G7 by the pandemic preparedness partnership.
A register of agreements relating to exclusion orders made by powers under paragraph 7 of Schedule 3 to The Competition Act 1998.
How to get fast-track approval of medical devices during COVID-19.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
The government has pledged £750 million to ensure VCSE can continue their vital work supporting the country during the coronavirus (COVID-19) outbreak, including £200 million for the Coronavirus Community Support Fund, along with an additional £150 million from dormant bank...
Information to support your recovery after COVID-19.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
This is advice for UK sponsors of workers and temporary workers affected by coronavirus (COVID-19).
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Coronavirus (COVID-19) vaccination consent form and letter templates for healthcare workers.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Data on the real-world efficacy of the COVID-19 vaccines.
Actions that trial sponsors should consider to build resilience into clinical trial design
An explanation of how holiday entitlement and pay operate during the pandemic, where it differs from the standard holiday entitlement and pay guidance.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).